Dendreon (DNDN) Gross Profit Margin starting from the third quarter 2014 to third quarter 2013, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Dendreon Corp  (DNDN)


Dendreon's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DNDN Gross Profit Margin (Sep 30 2014)
Q3 		(Jun 30 2014)
Q2 		(Mar 31 2014)
Q1 		(Dec 31 2013)
Q4 		(Sep 30 2013)
Q3
Y / Y Revenue Change 7.53 %
Seq. Revenue Change -11.05 %
Revenue In Millions $73.12
Gross Profit Margin 51.32 %
Gross Profit Margin Total Ranking # 2031
Gross Profit In Millions $37.52
Y / Y Gross Profit Change 78.1 %
Seq. Gross Profit Change -15.37 %


Commenting Third Quarter 2014 Gross Profit Margin
Dendreon Corp experienced contraction in Gross Profit by -15.37 % to $73 millions and Revenue by -11.05 %, while Gross Profit Margin fell to 51.32 %, above company*s average Gross Profit Margin.


Observing third quarter 2014 results within Biotechnology & Pharmaceuticals industry 22 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1592 to 2031.
Learn about Gross Margin
DNDN's Gross Profit Margin third quarter 2014 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 23
Healthcare Sector # 213
Overall # 1613

Gross Profit Margin Statistics
High Average Low
53.93 % 37.87 % 22.83 %
(Jun 30 2014)   (Jun 30 2012)


DNDN Gross Income Trends • More of DNDN's Profitabilty Ratios • DNDN Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
DNDN's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
DNDN's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for DNDN's Competitors
Gross Profit Margin Profit Margin for Dendreon's Suppliers
Gross Profit Margin Profit Margin for DNDN's Customers

You may also want to know
DNDN's Annual Growth Rates DNDN's Profitability Ratios DNDN's Asset Turnover Ratio DNDN's Dividend Growth
DNDN's Roe DNDN's Valuation Ratios DNDN's Financial Strength Ratios DNDN's Gross Profit Growth
DNDN's Roa DNDN's Inventory Turnover Ratio DNDN's Growth Rates DNDN's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2014, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginSep 30 2014 MRQ Gross ProfitSep 30 2014 MRQ Revenue
Pluri Inc   96.84 %$ 0.092  Millions$ 0.095  Millions
Noho, Inc.  95.11 %$ 0.268  Millions$ 0.281  Millions
Seagen Inc   93.77 %$ 71.128  Millions$ 75.853  Millions
Exelixis Inc   90.89 %$ 5.718  Millions$ 6.291  Millions
Biogen Inc   87.95 %$ 2,208.807  Millions$ 2,511.446  Millions
Gilead Sciences Inc   83.66 %$ 5,054.526  Millions$ 6,041.832  Millions
Zeo Scientifix Inc   81.69 %$ 0.004  Millions$ 0.005  Millions
Cyclo Therapeutics Inc   81.63 %$ 0.316  Millions$ 0.388  Millions
Lineage Cell Therapeutics Inc   80.61 %$ 0.960  Millions$ 1.191  Millions
Acorda Therapeutics Inc   80.58 %$ 85.386  Millions$ 105.961  Millions
Nutrastar International Inc.  80.54 %$ 8.992  Millions$ 11.165  Millions
Protalix Biotherapeutics inc   79.67 %$ 1.909  Millions$ 2.396  Millions
Amgen Inc   78.77 %$ 3,963.000  Millions$ 5,031.000  Millions
Ds Healthcare Group, Inc.  75.18 %$ 2.464  Millions$ 3.278  Millions
Bohai Pharmaceuticals Group, Inc.  71.62 %$ 39.209  Millions$ 54.743  Millions
China Biologic Products Holdings Inc   67.56 %$ 46.567  Millions$ 68.924  Millions
Bio techne Corp  67.36 %$ 73.066  Millions$ 108.477  Millions
Halozyme Therapeutics Inc   64.80 %$ 9.465  Millions$ 14.606  Millions
Xtant Medical Holdings Inc   64.30 %$ 5.436  Millions$ 8.454  Millions
Enzo Biochem Inc  59.19 %$ 14.694  Millions$ 24.824  Millions
Sorrento Therapeutics Inc   58.70 %$ 0.749  Millions$ 1.276  Millions
Nanostring Technologies Inc   57.30 %$ 7.072  Millions$ 12.343  Millions
Dendreon Corp  51.32 %$ 37.524  Millions$ 73.123  Millions
Windtree Therapeutics Inc  51.23 %$ 0.270  Millions$ 0.527  Millions
Novavax inc   50.97 %$ 4.187  Millions$ 8.214  Millions
Vericel Corporation  42.72 %$ 4.126  Millions$ 9.658  Millions
Adma Biologics Inc   36.48 %$ 0.498  Millions$ 1.366  Millions
Fresh Tracks Therapeutics Inc   33.41 %$ 1.150  Millions$ 3.442  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.